{"log_id": 8132276368811936263, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 2e-06, "average": 0.99941, "min": 0.994831}, "location": {"width": 581, "top": 115, "height": 88, "left": 321}, "words": "低分子量肝素钙注射液说明书"}, {"probability": {"variance": 1e-06, "average": 0.999153, "min": 0.997738}, "location": {"width": 119, "top": 221, "height": 30, "left": 181}, "words": "【药品名称】"}, {"probability": {"variance": 0.001962, "average": 0.980729, "min": 0.829189}, "location": {"width": 302, "top": 254, "height": 41, "left": 218}, "words": "通用名:低分子量肝素钙注射液"}, {"probability": {"variance": 7e-06, "average": 0.996757, "min": 0.993808}, "location": {"width": 223, "top": 305, "height": 33, "left": 221}, "words": "英文名: low-molecular"}, {"probability": {"variance": 0.016874, "average": 0.845841, "min": 0.711869}, "location": {"width": 280, "top": 292, "height": 35, "left": 503}, "words": " it Heparin Calcium Injectior"}, {"probability": {"variance": 0.058205, "average": 0.829769, "min": 0.360432}, "location": {"width": 260, "top": 347, "height": 37, "left": 222}, "words": "汉语拼: Difenziliang 6:"}, {"probability": {"variance": 0, "average": 0.968373, "min": 0.968373}, "location": {"width": 86, "top": 345, "height": 22, "left": 560}, "words": " Zhusheye"}, {"probability": {"variance": 0.005051, "average": 0.972082, "min": 0.667853}, "location": {"width": 800, "top": 366, "height": 65, "left": 224}, "words": "本品主要成分及其化学名称为:由猪肠粘膜获取的硫酸氨基葡聚糖〈肝票〉片段,钙盐"}, {"probability": {"variance": 2.9e-05, "average": 0.997026, "min": 0.986279}, "location": {"width": 111, "top": 442, "height": 32, "left": 225}, "words": "其结构式为"}, {"probability": {"variance": 0.029932, "average": 0.898535, "min": 0.553975}, "location": {"width": 52, "top": 658, "height": 21, "left": 406}, "words": "#2-12"}, {"probability": {"variance": 1.3e-05, "average": 0.997072, "min": 0.987074}, "location": {"width": 290, "top": 697, "height": 41, "left": 235}, "words": "平均分子量:小于8000道尔顿"}, {"probability": {"variance": 0.000692, "average": 0.990182, "min": 0.884182}, "location": {"width": 380, "top": 739, "height": 46, "left": 201}, "words": "【性状】本品为无色或几乎无色澄明液体"}, {"probability": {"variance": 1.3e-05, "average": 0.996207, "min": 0.989655}, "location": {"width": 119, "top": 795, "height": 34, "left": 203}, "words": "【药理毒理】"}, {"probability": {"variance": 0.006209, "average": 0.967073, "min": 0.616765}, "location": {"width": 822, "top": 809, "height": 63, "left": 241}, "words": "低分子量肝素钙(以下简称本品)是一种新型的抗凝血酶ⅢI(ATI)依赖性抗血栓形成药"}, {"probability": {"variance": 0.001824, "average": 0.985419, "min": 0.753336}, "location": {"width": 879, "top": 853, "height": 65, "left": 201}, "words": "其药理作用与普通肝素钠基本相似。普通肝素可分离抗血栓活性和抗血凝活性,血浆中凝血酶(即"}, {"probability": {"variance": 0.010294, "average": 0.965883, "min": 0.436766}, "location": {"width": 886, "top": 898, "height": 64, "left": 199}, "words": "因子Ia)活性与血凝关系密切,因子a活性与血栓形成关系较密切。由于本品抗因子Xa活性"}, {"probability": {"variance": 0.011535, "average": 0.95523, "min": 0.493092}, "location": {"width": 868, "top": 942, "height": 64, "left": 206}, "words": "与抗因子Ⅱa活性之比值为2.5-5.0,而普通肝素为1.0左右,因此,本品对体内,外血栓,动"}, {"probability": {"variance": 0.007097, "average": 0.981957, "min": 0.451363}, "location": {"width": 883, "top": 986, "height": 66, "left": 204}, "words": "静脉血栓的形成有抑制作用:本品能刺激内皮细胞释放组织因子凝血途径抑制物,和纤溶酶原活"}, {"probability": {"variance": 0.005643, "average": 0.969617, "min": 0.595596}, "location": {"width": 871, "top": 1033, "height": 62, "left": 207}, "words": "化物,不被血小板第4因于中和和对血小板功能亦无明显影响。本品对血检溶解有间接协同作用"}, {"probability": {"variance": 0.000619, "average": 0.991178, "min": 0.86083}, "location": {"width": 882, "top": 1076, "height": 63, "left": 208}, "words": "可用于治疗已形成的深部静脉血栓预防性抗血栓治疗只需每天皮下注射一次,一般不需实验室"}, {"probability": {"variance": 0.00066, "average": 0.967225, "min": 0.941529}, "location": {"width": 46, "top": 1156, "height": 25, "left": 210}, "words": "监测"}, {"probability": {"variance": 0.016777, "average": 0.95338, "min": 0.380536}, "location": {"width": 841, "top": 1164, "height": 62, "left": 253}, "words": "本品无三致(致突变,致畸胎致癌)毒性。给小白鼠静脉注射和皮下注射本最的L分别"}, {"probability": {"variance": 0.015017, "average": 0.937536, "min": 0.453411}, "location": {"width": 253, "top": 1234, "height": 39, "left": 213}, "words": "为165mg/kg.3764mg/g"}, {"probability": {"variance": 5e-06, "average": 0.997942, "min": 0.992629}, "location": {"width": 192, "top": 1277, "height": 42, "left": 221}, "words": "【药代动力学】"}, {"probability": {"variance": 0.014268, "average": 0.963122, "min": 0.357433}, "location": {"width": 833, "top": 1294, "height": 69, "left": 257}, "words": "本品的药代动力学参数由测定血浆抗因子Xa活性来确定,皮下注射时达到血浆峰值"}, {"probability": {"variance": 0.009256, "average": 0.977994, "min": 0.447224}, "location": {"width": 757, "top": 1342, "height": 68, "left": 216}, "words": "随后逐渐下降,直至用药后24小时仍可监测到,消除半衰期约3小时成"}, {"probability": {"variance": 0.017399, "average": 0.949017, "min": 0.39187}, "location": {"width": 717, "top": 1393, "height": 58, "left": 220}, "words": "时)。皮下注射的生物利用度98%,而肝素只有30%皮注射静脉注射本"}, {"probability": {"variance": 0, "average": 0.728393, "min": 0.728393}, "location": {"width": 134, "top": 1344, "height": 88, "left": 979}, "words": "贷"}, {"probability": {"variance": 0.012417, "average": 0.96075, "min": 0.355509}, "location": {"width": 866, "top": 1428, "height": 71, "left": 221}, "words": "子Xa活性剂量依赖地增加多数情况下不存在明显的个体差影按体重给药。静脉注射"}, {"probability": {"variance": 0.019931, "average": 0.947065, "min": 0.431123}, "location": {"width": 881, "top": 1475, "height": 64, "left": 224}, "words": "最高血浆抗因子xa活性大约是皮下注射的3倍。本品在肝脏代谢由肾脏消除:本品不能"}, {"probability": {"variance": 0.000257, "average": 0.988265, "min": 0.96104}, "location": {"width": 87, "top": 1553, "height": 30, "left": 225}, "words": "透过胎盘"}], "language": 3}